HET0016
HET0016 is a potent and selective 20-hydroxyeicosatetraenoic acid (20-HETE) synthase inhibitor, with IC50 values of 17.7 nM, 12.1 nM and 20.6 nM for recombinant CYP4A1-, CYP4A2- and CYP4A3-catalyzed 20-HETE synthesis, respectively. HET0016 also is a selective CYP450 inhibitor, which has been shown to inhibit angiogenesis and tumor growth[1][2].
Product Specifications
CAS Number
339068-25-6
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/het0016.html
Purity
99.69
Solubility
DMSO : 5 mg/mL (ultrasonic)
Smiles
CCCCC1=CC=C(C(C)=C1)/N=C/NO
Molecular Formula
C12H18N2O
Molecular Weight
206.28
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP4
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
KDR, phosphorylated (Y1175) (KDR, FLK1, VEGFR2, Vascular endothelial growth factor receptor 2, Fetal liver kinase 1, Kinase insert domain receptor, Protein-tyrosine kinase receptor flk-1) (APC) discontinued
Human Thyroid Stimulating Hormone (TSH) AssayLite™ Antibody (RPE Conjugate)
Rabbit Polyclonal mCherry Antibody [DyLight 405]
